| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Tamás Röszer | Q57323163 |
| P2093 | author name string | Attila Szanto | |
| P2860 | cites work | Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency | Q22010457 |
| Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes | Q22250883 | ||
| Macrophage scavenger receptor CD36 is the major receptor for LDL modified by monocyte-generated reactive nitrogen species | Q22253929 | ||
| Molecular cloning of a novel scavenger receptor for oxidized low density lipoprotein, SR-PSOX, on macrophages | Q24290466 | ||
| Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma | Q24311702 | ||
| PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL | Q24311741 | ||
| Activation of the nuclear receptor LXR by oxysterols defines a new hormone response pathway | Q24316367 | ||
| Reduction of atherosclerosis in mice by inhibition of CD40 signalling | Q24316540 | ||
| LXR, a nuclear receptor that defines a distinct retinoid response pathway | Q24317347 | ||
| Synthetic LXR ligand inhibits the development of atherosclerosis in mice | Q24530617 | ||
| Structural requirements of ligands for the oxysterol liver X receptors LXRalpha and LXRbeta | Q24553340 | ||
| Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice | Q24623151 | ||
| Antidiabetic PPAR gamma-activator rosiglitazone reduces MMP-9 serum levels in type 2 diabetic patients with coronary artery disease | Q44316923 | ||
| Influence of interferon-gamma on the extent and phenotype of diet-induced atherosclerosis in the LDLR-deficient mouse | Q44342113 | ||
| Inactivation of macrophage scavenger receptor class B type I promotes atherosclerotic lesion development in apolipoprotein E-deficient mice | Q44633973 | ||
| Macrophage migration inhibitory factor deficiency impairs atherosclerosis in low-density lipoprotein receptor-deficient mice | Q44936555 | ||
| Stem cell transplantation reveals that absence of macrophage CD36 is protective against atherosclerosis | Q45108277 | ||
| The mouse CCR2 gene is regulated by two promoters that are responsive to plasma cholesterol and peroxisome proliferator-activated receptor gamma ligands. | Q46003373 | ||
| Inhibition of IL-10-induced STAT3 activation by 15-deoxy-Delta12,14-prostaglandin J2. | Q46445868 | ||
| The PPARdelta agonist GW0742X reduces atherosclerosis in LDLR(-/-) mice | Q46530547 | ||
| Conditional knockout of macrophage PPARgamma increases atherosclerosis in C57BL/6 and low-density lipoprotein receptor-deficient mice | Q46537797 | ||
| Pioglitazone attenuates TGF-beta(1)-induction of fibronectin synthesis and its splicing variant in human mesangial cells via activation of peroxisome proliferator-activated receptor (PPAR)gamma | Q46626934 | ||
| Blockade of interleukin-12 function by protein vaccination attenuates atherosclerosis | Q46652738 | ||
| PPAR-gamma agonists inhibit toll-like receptor-mediated activation of dendritic cells via the MAP kinase and NF-kappaB pathways | Q46655077 | ||
| Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis | Q46897070 | ||
| Regulation of the Hedgehog and Wingless signalling pathways by the F-box/WD40-repeat protein Slimb | Q47070747 | ||
| Natural killer T cells accelerate atherogenesis in mice | Q47685326 | ||
| Markedly reduced bile acid synthesis but maintained levels of cholesterol and vitamin D metabolites in mice with disrupted sterol 27-hydroxylase gene | Q48010812 | ||
| Requirement for CD154 in the progression of atherosclerosis. | Q52536870 | ||
| Disruption of the sterol 27-hydroxylase gene in mice results in hepatomegaly and hypertriglyceridemia. Reversal by cholic acid feeding. | Q52541069 | ||
| Decreased atherosclerotic lesion formation in CX3CR1/apolipoprotein E double knockout mice. | Q52549466 | ||
| Granulocyte colony-stimulating factor and granulocyte macrophage colony-stimulating factor exacerbate atherosclerosis in apolipoprotein E-deficient mice. | Q53562008 | ||
| Liver X receptors regulate dendritic cell phenotype and function through blocked induction of the actin-bundling protein fascin. | Q53574931 | ||
| Impaired regulatory T-cell response and enhanced atherosclerosis in the absence of inducible costimulatory molecule. | Q53591929 | ||
| Activation of PPARalpha or gamma reduces secretion of matrix metalloproteinase 9 but not interleukin 8 from human monocytic THP-1 cells. | Q54256900 | ||
| Natural regulatory T cells control the development of atherosclerosis in mice | Q58149268 | ||
| A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection | Q59068486 | ||
| The role of PPAR-gamma in macrophage differentiation and cholesterol uptake. | Q42497873 | ||
| Exogenous interferon-gamma enhances atherosclerosis in apolipoprotein E-/- mice | Q42757050 | ||
| PPAR-gamma dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation | Q42832963 | ||
| 27-hydroxycholesterol is an endogenous ligand for liver X receptor in cholesterol-loaded cells | Q43706818 | ||
| Inhibition of transforming growth factor-beta signaling accelerates atherosclerosis and induces an unstable plaque phenotype in mice. | Q43794492 | ||
| Loss of SR-BI expression leads to the early onset of occlusive atherosclerotic coronary artery disease, spontaneous myocardial infarctions, severe cardiac dysfunction, and premature death in apolipoprotein E-deficient mice | Q43893171 | ||
| Interleukin-4 deficiency decreases atherosclerotic lesion formation in a site-specific manner in female LDL receptor-/- mice | Q43909351 | ||
| Subendothelial retention of atherogenic lipoproteins in early atherosclerosis | Q44029239 | ||
| Interleukin 12 induces T-cell recruitment into the atherosclerotic plaque | Q44043461 | ||
| Selective interleukin-12 synthesis defect in 12/15-lipoxygenase-deficient macrophages associated with reduced atherosclerosis in a mouse model of familial hypercholesterolemia | Q44066949 | ||
| Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis | Q44121998 | ||
| Atherosclerosis | Q24644573 | ||
| Control of cellular cholesterol efflux by the nuclear oxysterol receptor LXR alpha | Q24683359 | ||
| Parallel SUMOylation-dependent pathways mediate gene- and signal-specific transrepression by LXRs and PPARgamma | Q24685818 | ||
| The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease | Q28141040 | ||
| Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1 | Q28141056 | ||
| Human white/murine ABC8 mRNA levels are highly induced in lipid-loaded macrophages. A transcriptional role for specific oxysterols | Q28143718 | ||
| A PPAR gamma-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis | Q28199913 | ||
| Reciprocal regulation of inflammation and lipid metabolism by liver X receptors | Q28202771 | ||
| Transcriptional repression of atherogenic inflammation: modulation by PPARdelta | Q28206569 | ||
| Liver X receptor (LXR) regulation of the LXRalpha gene in human macrophages | Q28215677 | ||
| CXCL16 is a marker of inflammation, atherosclerosis, and acute coronary syndromes in humans | Q28218369 | ||
| An oxysterol signalling pathway mediated by the nuclear receptor LXR alpha | Q28294042 | ||
| MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment | Q28298072 | ||
| A major role for VCAM-1, but not ICAM-1, in early atherosclerosis | Q28365883 | ||
| Oxysterols present in atherosclerotic tissue decrease the expression of lipoprotein lipase messenger RNA in human monocyte-derived macrophages | Q28378773 | ||
| Interleukin-4-dependent production of PPAR-gamma ligands in macrophages by 12/15-lipoxygenase | Q28587071 | ||
| Reduced atherosclerosis in interleukin-18 deficient apolipoprotein E-knockout mice | Q28591350 | ||
| A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-gamma | Q28593737 | ||
| Activities of recombinant human cytochrome P450c27 (CYP27) which produce intermediates of alternative bile acid biosynthetic pathways | Q28613243 | ||
| Cerebrotendinous Xanthomatosis | Q29307222 | ||
| Inflammation in atherosclerosis | Q29547428 | ||
| Atherosclerosis. the road ahead | Q29618972 | ||
| The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation | Q29620219 | ||
| Dual promoter structure of mouse and human fatty acid translocase/CD36 genes and unique transcriptional activation by peroxisome proliferator-activated receptor alpha and gamma ligands | Q30819886 | ||
| Troglitazone inhibits atherosclerosis in apolipoprotein E-knockout mice: pleiotropic effects on CD36 expression and HDL. | Q32085397 | ||
| Gene expression changes in foam cells and the role of chemokine receptor CCR7 during atherosclerosis regression in ApoE-deficient mice | Q33236495 | ||
| Activation of liver X receptors and retinoid X receptors prevents bacterial-induced macrophage apoptosis | Q33581637 | ||
| Loss of receptor-mediated lipid uptake via scavenger receptor A or CD36 pathways does not ameliorate atherosclerosis in hyperlipidemic mice | Q33905765 | ||
| Sterol 27-hydroxylase deficiency: a rare cause of xanthomas in normocholesterolemic humans. | Q33944867 | ||
| Decreased atherosclerosis in mice deficient in both macrophage colony-stimulating factor (op) and apolipoprotein E | Q33962949 | ||
| Autoregulation of the human liver X receptor alpha promoter | Q34012691 | ||
| Modulation of atherosclerosis in mice by Toll-like receptor 2 | Q34063165 | ||
| Conditional disruption of the peroxisome proliferator-activated receptor gamma gene in mice results in lowered expression of ABCA1, ABCG1, and apoE in macrophages and reduced cholesterol efflux. | Q34277079 | ||
| Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques | Q34327535 | ||
| PPARdelta is a very low-density lipoprotein sensor in macrophages | Q34330290 | ||
| Reduced cholesterol absorption upon PPARdelta activation coincides with decreased intestinal expression of NPC1L1. | Q34377352 | ||
| Identification of bile acid precursors as endogenous ligands for the nuclear xenobiotic pregnane X receptor | Q34467451 | ||
| Adipocyte enhancer-binding protein 1 is a potential novel atherogenic factor involved in macrophage cholesterol homeostasis and inflammation | Q34478995 | ||
| Reduction of atherosclerosis in apolipoprotein E knockout mice by activation of the retinoid X receptor. | Q34479025 | ||
| Peroxisome proliferator-activated receptor delta promotes very low-density lipoprotein-derived fatty acid catabolism in the macrophage | Q34479176 | ||
| Oxidatively modified low density lipoproteins: a potential role in recruitment and retention of monocyte/macrophages during atherogenesis | Q34620005 | ||
| Pattern recognition receptors: doubling up for the innate immune response | Q35036522 | ||
| Dual role for scavenger receptor class B, type I on bone marrow-derived cells in atherosclerotic lesion development | Q35103176 | ||
| PPARgamma and PPARdelta negatively regulate specific subsets of lipopolysaccharide and IFN-gamma target genes in macrophages | Q35144057 | ||
| Expression of peroxisome proliferator-activated receptor-gamma in macrophage suppresses experimentally induced colitis | Q35633338 | ||
| 15-deoxy-delta 12,14-prostaglandin J2 inhibits multiple steps in the NF-kappa B signaling pathway. | Q35698498 | ||
| The role of interleukin-4 and interleukin-12 in the progression of atherosclerosis in apolipoprotein E-deficient mice | Q35792034 | ||
| Thematic review series: The immune system and atherogenesis. Paying the price for pathogen protection: toll receptors in atherogenesis | Q36011463 | ||
| Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for CD40-CD40 ligand signaling in atherosclerosis | Q36028683 | ||
| PPARgamma controls CD1d expression by turning on retinoic acid synthesis in developing human dendritic cells | Q36227984 | ||
| CD1d-dependent activation of NKT cells aggravates atherosclerosis. | Q36399122 | ||
| Expression of the peroxisome proliferator-activated receptor gamma (PPARgamma) in human atherosclerosis and regulation in macrophages by colony stimulating factors and oxidized low density lipoprotein | Q36501176 | ||
| The immune response in atherosclerosis: a double-edged sword | Q36508676 | ||
| Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E | Q36986664 | ||
| Peroxisome proliferator-activated receptor gamma ligands inhibit development of atherosclerosis in LDL receptor-deficient mice | Q37242527 | ||
| Oxidized LDL reduces monocyte CCR2 expression through pathways involving peroxisome proliferator-activated receptor gamma | Q37270009 | ||
| Cross-regulatory roles of interleukin (IL)-12 and IL-10 in atherosclerosis. | Q37354660 | ||
| Absence of P-selectin delays fatty streak formation in mice | Q37364649 | ||
| IFN-gamma potentiates atherosclerosis in ApoE knock-out mice | Q37368296 | ||
| A leukocyte homologue of the IL-8 receptor CXCR-2 mediates the accumulation of macrophages in atherosclerotic lesions of LDL receptor-deficient mice | Q37377448 | ||
| The combined role of P- and E-selectins in atherosclerosis | Q37387115 | ||
| LXR-dependent gene expression is important for macrophage survival and the innate immune response | Q38335500 | ||
| Peroxisome proliferator-activated receptor-gamma ligands inhibit TGF-beta 1-induced fibronectin expression in glomerular mesangial cells | Q38346577 | ||
| Transcriptional regulation of human CYP27 integrates retinoid, peroxisome proliferator-activated receptor, and liver X receptor signaling in macrophages | Q39961619 | ||
| PPARgamma agonists prevent TGFbeta1/Smad3-signaling in human hepatic stellate cells | Q40225700 | ||
| A role for the apoptosis inhibitory factor AIM/Spalpha/Api6 in atherosclerosis development | Q40391470 | ||
| Peroxisome proliferation-activated receptor (PPAR)gamma is not necessary for synthetic PPARgamma agonist inhibition of inducible nitric-oxide synthase and nitric oxide | Q40517615 | ||
| Crosstalk between LXR and Toll-like Receptor Signaling Mediates Bacterial and Viral Antagonism of Cholesterol Metabolism | Q40622775 | ||
| Regulation of ATP-binding cassette sterol transporters ABCG5 and ABCG8 by the liver X receptors alpha and beta. | Q40743941 | ||
| The Yin and Yang of oxidation in the development of the fatty streak. A review based on the 1994 George Lyman Duff Memorial Lecture | Q41010478 | ||
| Inflammatory cytokines and oxidized low density lipoproteins increase endothelial cell expression of membrane type 1-matrix metalloproteinase | Q41646524 | ||
| PPARgamma regulates adipocyte cholesterol metabolism via oxidized LDL receptor 1 | Q42109973 | ||
| Liver X receptor-dependent repression of matrix metalloproteinase-9 expression in macrophages | Q42435836 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | inflammation | Q101991 |
| P304 | page(s) | 106-116 | |
| P577 | publication date | 2007-11-20 | |
| P1433 | published in | FEBS Letters | Q1388051 |
| P1476 | title | Nuclear receptors in macrophages: a link between metabolism and inflammation | |
| P478 | volume | 582 |
| Q37878285 | Do PPAR-Gamma Agonists Have a Future in Parkinson's Disease Therapy? |
| Q33638451 | Genome-wide expression profiling deciphers host responses altered during dengue shock syndrome and reveals the role of innate immunity in severe dengue |
| Q30416015 | Implication of inflammatory macrophages, nuclear receptors, and interferon regulatory factors in increased virulence of pandemic 2009 H1N1 influenza A virus after host adaptation |
| Q47386444 | Macrophage polarization and meta-inflammation |
| Q92408379 | MicroRNA Regulated Macrophage Activation in Obesity |
| Q55085773 | Peroxisome Proliferator-Activated Receptor-γ Modulates the Response of Macrophages to Lipopolysaccharide and Glucocorticoids. |
| Q54696552 | Polyphenol-rich grape powder extract (GPE) attenuates inflammation in human macrophages and in human adipocytes exposed to macrophage-conditioned media. |
| Q39609098 | Quercetin attenuates inflammation in human macrophages and adipocytes exposed to macrophage-conditioned media |
| Q37983640 | Role and function of macrophages in the metabolic syndrome |
| Q64955233 | Role of Myeloid-Epithelial-Reproductive Tyrosine Kinase and Macrophage Polarization in the Progression of Atherosclerotic Lesions Associated With Nonalcoholic Fatty Liver Disease. |
| Q35641892 | Synthesis and evaluation of 18F-labeled PPARγ antagonists |
| Q35600280 | The PPAR-γ antagonist GW9662 elicits differentiation of M2c-like cells and upregulation of the MerTK/Gas6 axis: a key role for PPAR-γ in human macrophage polarization |
| Q28585275 | The bile acid sensor FXR is required for immune-regulatory activities of TLR-9 in intestinal inflammation |
| Q37434429 | Tobacco smoke affects expression of peroxisome proliferator-activated receptor-gamma in monocyte/macrophages of patients with coronary heart disease |
| Q37486151 | Xenobiotic Receptor-Mediated Regulation of Intestinal Barrier Function and Innate Immunity |
Search more.